
### [NCIT:C80683](http://purl.obolibrary.org/obo/NCIT_C80683)
**Label:** Therapy-Related Leukemia

**Subclasses:** [NCIT:C80691](http://purl.obolibrary.org/obo/NCIT_C80691) (Chemotherapy-Related Leukemia), [NCIT:C27755](http://purl.obolibrary.org/obo/NCIT_C27755) (Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia), [NCIT:C27754](http://purl.obolibrary.org/obo/NCIT_C27754) (Alkylating Agent-Related Acute Myeloid Leukemia), [NCIT:C8252](http://purl.obolibrary.org/obo/NCIT_C8252) (Therapy-Related Acute Myeloid Leukemia), 

**Class expressions from DL-Learner:**

- [UBERON:0002371](http://purl.obolibrary.org/obo/UBERON_0002371) (bone marrow) 55.56%
- [NCIT:C37181](http://purl.obolibrary.org/obo/NCIT_C37181) (Neoplastic Monoblast) 55.56%
- [NCIT:C37076](http://purl.obolibrary.org/obo/NCIT_C37076) (Neoplastic Neutrophilic Precursor) 55.56%
- [NCIT:C37075](http://purl.obolibrary.org/obo/NCIT_C37075) (Neoplastic Promonocyte) 55.56%
- [NCIT:C37041](http://purl.obolibrary.org/obo/NCIT_C37041) (Neoplastic Monocyte) 55.56%
- [NCIT:C37040](http://purl.obolibrary.org/obo/NCIT_C37040) (Abnormal Monocyte) 55.56%
- [NCIT:C36371](http://purl.obolibrary.org/obo/NCIT_C36371) (t(11;19)(q23;p13.1)) 55.56%
- [NCIT:C36366](http://purl.obolibrary.org/obo/NCIT_C36366) (t(9;11)(q21;q23)) 55.56%
- [NCIT:C37040](http://purl.obolibrary.org/obo/NCIT_C37040) (Abnormal Monocyte) and [NCIT:C41063](http://purl.obolibrary.org/obo/NCIT_C41063) (Neoplastic Myeloid Cell) 55.56%
- [NCIT:C41063](http://purl.obolibrary.org/obo/NCIT_C41063) (Neoplastic Myeloid Cell) 53.43%
- Thing 53.05%
- [NCIT:C37042](http://purl.obolibrary.org/obo/NCIT_C37042) (Abnormal Myeloid Cell) 47.54%
- [NCIT:C37060](http://purl.obolibrary.org/obo/NCIT_C37060) (Neoplastic Hematopoietic and Lymphoid Cell) 45.12%
- [NCIT:C36987](http://purl.obolibrary.org/obo/NCIT_C36987) (Abnormal Hematopoietic and Lymphoid Cell) 43.76%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 39.41%


